To study the differential expression of SH3BGRL3 and circSH3BGRL3 between primary AML patients and normal samples, we collected and used clinical blood samples from 13 AML patients and 13 normal individuals (controls) for qRT-PCR analysis (Figures 5A, B). This evidence concerns the gene SH3BGRL3 and acute myeloid leukemia.